[Phosphodiesterase III inhibitor--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
Sato, Naoki
[Phosphodiesterase III inhibitor--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects]. [electronic resource] - Nihon rinsho. Japanese journal of clinical medicine May 2007 - 43-8 p. digital
Publication Type: Journal Article; Review
0047-1852
3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors
Cardiotonic Agents--administration & dosage
Clinical Trials as Topic
Contraindications
Cyclic AMP--metabolism
Cyclic Nucleotide Phosphodiesterases, Type 3
Humans
Imidazoles
Milrinone
Phosphodiesterase Inhibitors--administration & dosage
Pyridazines
Pyridones
[Phosphodiesterase III inhibitor--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects]. [electronic resource] - Nihon rinsho. Japanese journal of clinical medicine May 2007 - 43-8 p. digital
Publication Type: Journal Article; Review
0047-1852
3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors
Cardiotonic Agents--administration & dosage
Clinical Trials as Topic
Contraindications
Cyclic AMP--metabolism
Cyclic Nucleotide Phosphodiesterases, Type 3
Humans
Imidazoles
Milrinone
Phosphodiesterase Inhibitors--administration & dosage
Pyridazines
Pyridones